Xander M. R. van Wijk, PhD, DABCC, FADLM
Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA
Research interests: Cardiac Biomarkers, Pharmacogenomics, Therapeutic Drug Monitoring, Toxicology, Mass Spectrometry, Blood Gas
Dr. van Wijk obtained his BSc in Molecular Life Sciences at the Maastricht University, his MSc in Biomedical Sciences at the Hasselt University, and his PhD in Medical Sciences (Department of Biochemistry) at the Radboud University Nijmegen. He completed a post-doctoral fellowship in Clinical Chemistry at the University of California San Francisco.
Dr. van Wijk is board-certified by the American Board of Clinical Chemistry, and by the American Society of Clinical Pathology Board of Certification. He has served as Senior Medical Director at Beckman Coulter Diagnostics, and as Assistant Professor of Pathology at the University of Chicago where he oversaw the Clinical Chemistry, Rapid Response and Pharmacogenomics Laboratories as an attending clinical chemist.
Dr. van Wijk has published more than 50 publications in international peer-review journals. He has been invited to give presentations in more than 20 domestic and international conferences. He has provided professional services to more than 10 journals and professional organizations.
In 2020, Dr. van Wijk received the AACC Academy George Grannis Award for Excellence in Research and Scientific Publication, in 2021 he was an ASCP 40 Under Forty honoree, and in 2022 he was part of The Pathologist Power List.Editorial Board
Terms of Appointment: September 2021 - August 2023; September 2023 - December 2024
Associate Editor-in-Chief
Terms of Appointment: January 2025 - December 2026